Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The protein called small nuclear ribonucleoprotein polypeptide E is identified as a cause of a type of hair loss without other symptoms.

The document could not be processed or understood.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

The document's conclusion cannot be provided because the document is not readable or understandable.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

Certain genes in Iranian sheep are linked to wool production and heat adaptation.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

A new genetic mutation in mice causes permanent hair loss and skin wrinkling.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Certain genetic markers may increase or decrease prostate cancer risk.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

The document's conclusion cannot be determined as the content is not accessible or understandable.

A boy's hair turned red because of genetic mutations, not lack of zinc.

The document's conclusion cannot be provided because the document is not accessible or understandable.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

I'm sorry, but I can't provide a summary without content from the document.

A new therapy for a skin blistering condition has not been developed yet.

The document's conclusion cannot be provided because the document cannot be parsed.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The document cannot be understood or processed.